Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Olivier Hermine, Pr
Hopital Necker - Paris
Principal Investigator - Steven Le Gouill, Pr
Nantes University Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu D'Amiens
Amiens, France
- Chu D'Angers
Angers, France
- Ch D'Avignon
Avignon, France
- Chu de Caen
Caen, France
- Chu de Clermont Ferrand
Clermont-Ferrand, France
- Hopital Henri Mondor
Créteil, France
- Chu de Dijon - Hôpital Le Bocage
Dijon, France
- Chu de Grenoble
Grenoble, France
- Chd Vendée
La Roche-sur-Yon, France
- Clinique Victor Hugo
Le Mans, France
- Chru Lille - Hôpital Claude Huriez
Lille, France
- Chu Limoges
Limoges, France
- Chu Montpellier
Montpellier, France
- Chu Nantes
Nantes, France
- Aphp - Hopital Necker
Paris, France
- Hôpital Saint Louis
Paris, France
- Ch Perpignan
Perpignan, France
- Chu de Haut Leveque
Pessac, France
- Chu Lyon Sud
Pierre-Bénite, France
- Chu de Poitiers
Poitiers, France
- Centre Hospitalier Annecy-Genevois
Pringy, France
- Chu Robert Debré
Reims, France
- Chu Pontchaillou
Rennes, France
- Centre Henri Becquerel
Rouen, France
- Institut de Cancérologie de Loire
Saint-Priest-en-Jarez, France
- Chu de Strasbourg
Strasbourg, France
- I.U.C.T Oncopole
Toulouse, France
- Chru Bretonneau
Tours, France
- Chu de Brabois
Vandœuvre-lès-Nancy, France
- Gustave Roussy Cancer Campus
Villejuif, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2016
- Primary completion
- 31 Mar 2019
- Completion
- 2 Dec 2024
- Last update posted
- 14 Jan 2026
- Registered enrollment
- 86
- Registry id
- NCT02896582
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.